Press "esc" to clear
Go to Advanced Search

Showing results

110 of 539

Article ID: 693245

Body's Natural High, Prescription Drug Misuse, Health Implications of Legalized Marijuana, and More in the Marijuana News Source

Newswise

The Latest News On Marijuana Research

Released:
20-Apr-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab Add to Favorites
Comment

Article ID: 693092

Low Total Testosterone in Men Widespread, Linked to Chronic Disease

Michigan Medicine - University of Michigan

New research finds that more men have suboptimal testosterone levels than previously known, and it may be putting these men at risk.

Released:
19-Apr-2018 4:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Peng_Weiyi.jpg
  • Embargo expired:
    17-Apr-2018 8:00 AM EDT

Article ID: 692864

Combination Therapy Strengthens T Cells in Melanoma Pre-Clinical Study

University of Texas M. D. Anderson Cancer Center

A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.

Released:
16-Apr-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
FryHowardM.D.labcoat2014.jpg

Article ID: 692921

What is Testicular Cancer?

Valley Health System

Testicular cancer is the most common form of cancer in men ages 15 to 35. The American Cancer Society (ACS) estimates that there will be approximately 9,310 new cases of testicular cancer diagnosed in the United States in 2018.Testicular cancer grows in the tissues of one or both testes—glands that are located in the scrotum. Most cases of testicular cancer start out in the sperm-making cells known as germ cells. Testicular cancer can be classified into seminoma and nonseminoma. Although aggressive, both cancer types are curable even when metastatic.

Released:
16-Apr-2018 4:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692685

Man-Made Antibodies Show Promise in Attacking Cancer Cells in Animal Models

Duke Health

Using chemotherapy along with aptamers -- lab-made molecules that function like antibodies -- Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed.

Released:
16-Apr-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
sceinceimage_dokholyan_1copy.jpg
  • Embargo expired:
    16-Apr-2018 3:00 PM EDT

Article ID: 692615

Large Aggregates of ALS-Causing Protein Might Actually Help Brain Cells

University of North Carolina Health Care System

UNC School of Medicine scientists led by Nikolay Dokholyan add to evidence that small aggregates of SOD1 protein are the brain-cell killing culprits in ALS, but the formation of larger, more visible, and fibril-like aggregates of the same protein may protect brain cells.

Released:
11-Apr-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Philip.Owens.jpg
  • Embargo expired:
    16-Apr-2018 12:00 PM EDT

Article ID: 692460

When Prostate Cancer Reaches Bone, Bone Cells May Drive Overall Growth of the Disease

University of Colorado Cancer Center

When prostate cancer metastasizes to bone, it can become especially dangerous – CU Cancer Center study at AACR18 hints at why: Cells involved in these bone metastases may release signals that drive the progression of the disease.

Released:
9-Apr-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
PAPHOriginal.jpg

Article ID: 692387

Expanded Rush Program Provides Relief from Pelvic Floor Conditions

Rush University Medical Center

Newly expanded, the Program for Abdominal and Pelvic Health at Rush brings together a team of experts to address the complexity of pelvic health conditions and treat men and women suffering from them.

Released:
6-Apr-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692299

Negative Fateful Life Events and the Brains of Middle-Aged Men

University of California San Diego Health

Conflict, a death in the family, financial hardship and serious medical crises are all associated with accelerated physical aging. In a new study, researchers at the University of California San Diego School of Medicine found that such negative fateful life events — or FLEs — appear to also specifically accelerate aging in the brain.

Released:
5-Apr-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692141

How to Fight Side Effects of Hormone Therapy for Prostate Cancer

Ohio State University

Men on hormone therapy for prostate cancer may benefit significantly from hitting the gym with fellow patients and choosing more veggies and fewer cheeseburgers, a new study suggests.

Released:
3-Apr-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 539





Chat now!